Updated Jul 16, 2026
Ofman Joshua J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $12.93M.
Joshua J. Ofman is the President of GRAIL, Inc., a healthcare company focused on early cancer detection technologies. He has been involved in the company through multiple SEC filings, indicating a significant role in its operations.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | GRAL | GRAIL, Inc. | A — Grant or award | 3.2K | $61.13 | $193K |
| 2026-06-04 | GRAL | GRAIL, Inc. | A — Grant or award | 27.9K | $64.40 | $1.80M |
| 2026-04-09 | GRAL | GRAIL, Inc. | S — Open-market sale | 61.7K | $49.92 | $3.08M |
| 2026-03-10 | GRAL | GRAIL, Inc. | S — Open-market sale | 101 | $46.74 | $5K |
| 2026-03-10 | GRAL | GRAIL, Inc. | S — Open-market sale | 2.8K | $47.93 | $136K |
| 2026-03-10 | GRAL | GRAIL, Inc. | S — Open-market sale | 690 | $53.01 | $37K |
| 2026-03-04 | GRAL | GRAIL, Inc. | S — Open-market sale | 16.2K | $50.09 | $813K |
| 2026-03-04 | GRAL | GRAIL, Inc. | S — Open-market sale | 779 | $51.75 | $40K |
| 2026-03-04 | GRAL | GRAIL, Inc. | A — Grant or award | 84.5K | $53.23 | $4.50M |
| 2025-12-05 | GRAL | GRAIL, Inc. | S — Open-market sale | 13.0K | $100.00 | $1.30M |
| 2025-10-15 | GRAL | GRAIL, Inc. | S — Open-market sale | 6.1K | $82.01 | $501K |
| 2025-10-15 | GRAL | GRAIL, Inc. | S — Open-market sale | 8.9K | $76.03 | $674K |
| 2025-10-06 | GRAL | GRAIL, Inc. | S — Open-market sale | 81.4K | $62.50 | $5.09M |
| 2025-10-02 | GRAL | GRAIL, Inc. | S — Open-market sale | 9.7K | $64.00 | $620K |
| 2025-08-19 | GRAL | GRAIL, Inc. | S — Open-market sale | 4.2K | $32.02 | $135K |
| 2025-06-30 | GRAL | GRAIL, Inc. | S — Open-market sale | 9.7K | $52.00 | $504K |
| 2024-10-07 | GRAL | GRAIL, Inc. | A — Grant or award | 152.8K | $12.57 | $1.92M |
| 2024-10-07 | GRAL | GRAIL, Inc. | A — Grant or award | 107.0K | $12.57 | $1.34M |
Joshua J. Ofman is the President of GRAIL, Inc., a healthcare company focused on early cancer detection technologies. He has been involved in the company through multiple SEC filings, indicating a significant role in its operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 13 open-market sales ($12.93M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ofman Joshua J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.